These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 9098190)

  • 41. A comparative study of F-18 FDG PET and 201Tl scintigraphy for detection of primary malignant bone and soft-tissue tumors.
    Yamamoto Y; Kawaguchi Y; Kawase Y; Maeda Y; Nishiyama Y
    Clin Nucl Med; 2011 Apr; 36(4):290-4. PubMed ID: 21368603
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The value of Tc-99m-tetrofosmin scintigraphy in the assessment of P-glycoprotein in patients with malignant bone and soft-tissue tumors.
    Yapar Z; Kibar M; Yapar AF; Uguz A; Ozbarlas S; Gonlusen G
    Ann Nucl Med; 2003 Sep; 17(6):443-9. PubMed ID: 14575377
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Quantified 99mTc-MIBI scintigraphy for predicting chemotherapy response in breast cancer patients: factors that influence the level of 99m Tc-MIBI uptake.
    Fuster D; Muñoz M; Pavia J; Palacín A; Bellet N; Mateos JJ; Martín F; Ortega M; Setoain FJ; Pons F
    Nucl Med Commun; 2002 Jan; 23(1):31-8. PubMed ID: 11748435
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Technetium 99-m sestamibi bone scan in musculo-skeletal neoplasms].
    Robinson D; Pinkas L; Mindlin L; Halperin N; Horn T
    Harefuah; 1997 Dec; 133(11):509-14, 592. PubMed ID: 9451886
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Myositis ossificans demonstrated by positive gallium-67 and technetium-99m-HMDP bone imaging but negative technetium-99m-MIBI imaging.
    Shih WJ; Hackett MT; Stipp V; Gross K; Pulmano C
    J Nucl Med Technol; 1999 Mar; 27(1):48-50. PubMed ID: 10322577
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Clinical evaluation of tumor scintigraphy with 99mTc-bleomycin. (Part II). Combined studies of tumor scintigraphy with 99mTc-BLM and 67Ga-citrate, bone scintigraphy and angiography in bone and soft tissue tumors (author's transl)].
    Odori T
    Kaku Igaku; 1979 Sep; 16(6):829-47. PubMed ID: 93151
    [No Abstract]   [Full Text] [Related]  

  • 47. [99mTc-MAA perfusion studies in the treatment of preoperative intra-arterial infusion chemotherapy of malignant bone and soft tissue sarcoma].
    Satoh M; Takeuchi S; Kasai C; Kushida Y
    Gan To Kagaku Ryoho; 1988 Aug; 15(8 Pt 2):2359-65. PubMed ID: 3415248
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Usefulness of 99mTc-MIBI SPECT in the metastatic lesions of thyroid cancer].
    Kobayashi M; Mogami T; Uchiyama M; Moriya E; Mori Y; Ohtani Y; Kawakami K; Asahara R
    Nihon Igaku Hoshasen Gakkai Zasshi; 1997 Feb; 57(3):127-32. PubMed ID: 9077095
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison between thallium-201, technetium-99m-sestamibi and technetium-99m-teboroxime planar myocardial perfusion imaging in detection of coronary artery disease.
    Taillefer R; Lambert R; Essiambre R; Phaneuf DC; Léveillé J
    J Nucl Med; 1992 Jun; 33(6):1091-8. PubMed ID: 1534575
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of 99mTc-methoxyisobutyl isonitrile and 201T1 scintigraphy in visualization of suppressed thyroid tissue.
    Erdil TY; Onsel C; Kanmaz B; Caner B; Sönmezoğlu K; Ciftçi I; Turoğlu T; Kabasakal L; Sayman HB; Uslu I
    J Nucl Med; 2000 Jul; 41(7):1163-7. PubMed ID: 10914905
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical significance of thallium-201 scintigraphy in bone and soft tissue tumors.
    Goto Y; Ihara K; Kawauchi S; Ohi R; Sasaki K; Kawai S
    J Orthop Sci; 2002; 7(3):304-12. PubMed ID: 12077654
    [TBL] [Abstract][Full Text] [Related]  

  • 52. 99mTc-tetrofosmin scintigraphy in musculoskeletal tumours: the relationship between P-glycoprotein expression and tetrofosmin uptake in malignant lesions.
    Yapar Z; Kibar M; Ozbarlas S; Yapar AF; Uguz A; Zorludemir S; Herdem M
    Nucl Med Commun; 2002 Oct; 23(10):991-1000. PubMed ID: 12352598
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Relationship of cell proliferation (Ki-67) to 99mTc-(V)DMSA uptake in breast cancer.
    Papantoniou VJ; Souvatzoglou MA; Valotassiou VJ; Louvrou AN; Ambela C; Koutsikos J; Lazaris D; Christodoulidou JK; Sotiropoulou MG; Melissinou MJ; Perperoglou A; Tsiouris S; Zerva CJ
    Breast Cancer Res; 2004; 6(2):R56-62. PubMed ID: 14979918
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Assessment of chemosensitivity in patients with malignant bone and soft tissue tumors using thallium-201 scintigraphy and doxorubicin binding assay.
    Murata H; Kusuzaki K; Takeshita H; Hirata M; Hashiguchi S; Emoto K; Ashihara T; Hirasawa Y
    Anticancer Res; 2000; 20(5C):3967-70. PubMed ID: 11268485
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Potential of (99m)Tc-MIBI for detecting bone marrow metastases.
    Wakasugi S; Noguti A; Katuda T; Hashizume T; Hasegawa Y
    J Nucl Med; 2002 May; 43(5):596-602. PubMed ID: 11994520
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The role of nuclear medicine in primary bone and soft tissue tumors.
    Abdel-Dayem HM
    Semin Nucl Med; 1997 Oct; 27(4):355-63. PubMed ID: 9364645
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Triple-phase contrast-enhanced MRI for the prediction of preoperative chemotherapeutic effect in patients with osteosarcoma: comparison with (99m)Tc-MIBI scintigraphy.
    Wakabayashi H; Saito J; Taki J; Hashimoto N; Tsuchiya H; Gabata T; Kinuya S
    Skeletal Radiol; 2016 Jan; 45(1):87-95. PubMed ID: 26385785
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Technetium-99m-MIBI and thallium-201 scintigraphy of primary lung cancer.
    Nishiyama Y; Kawasaki Y; Yamamoto Y; Fukunaga K; Satoh K; Takashima H; Ohkawa M; Tanabe M
    J Nucl Med; 1997 Sep; 38(9):1358-61. PubMed ID: 9293787
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Technetium-99m-MIBI scintigraphy in pulmonary tuberculosis.
    Onsel C; Sönmezoglu K; Camsari G; Atay S; Cetin S; Erdil YT; Uslu I; Uzun A; Kanmaz B; Sayman HB
    J Nucl Med; 1996 Feb; 37(2):233-8. PubMed ID: 8667051
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The use of non-specific tracers in the follow up of differentiated thyroid cancer: results with Tc-99m tetrofosmin whole body scintigraphy.
    Lind P; Gallowitsch HJ
    Acta Med Austriaca; 1996; 23(1-2):69-75. PubMed ID: 8767519
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.